{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Anethum graveolens", "Dynamics simulation", "Molecular docking", "Momordica charantia", "Pancreatic lipase inhibition"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": [], "OtherID": [], "GeneralNote": [], "PMID": "38304787", "DateRevised": {"Year": "2024", "Month": "02", "Day": "03"}, "Article": {"Language": ["eng"], "ELocationID": ["e24907", "10.1016/j.heliyon.2024.e24907"], "ArticleDate": [{"Year": "2024", "Month": "01", "Day": "18"}], "Journal": {"ISSN": "2405-8440", "JournalIssue": {"Volume": "10", "Issue": "2", "PubDate": {"Year": "2024", "Month": "Jan", "Day": "30"}}, "Title": "Heliyon", "ISOAbbreviation": "Heliyon"}, "ArticleTitle": "Synergistic effects of <i>Momordica charantia</i>, <i>Nigella sativa</i>, and <i>Anethum graveolens</i> on metabolic syndrome targets: <i>In vitro</i> enzyme inhibition and in silico analyses.", "Pagination": {"StartPage": "e24907", "MedlinePgn": "e24907"}, "Abstract": {"AbstractText": ["M<i>omordica charantia, Nigella sativa,</i> and <i>Anethum graveolens</i> are established medicinal plants possessing noted anti-diabetic and anti-obesity properties. However, the molecular mechanisms underscoring their inhibitory effects on pancreatic lipase, \u03b1-glucosidase, and HMG-CoA reductase remain unexplored. This study aimed to elucidate the efficacy of various NS, MC, and AG blends in modulating the enzymatic activity of pancreatic lipase, HMG-CoA reductase, and a-glucosidase, utilizing an integrative approach combining <i>in vitro</i> assessments and molecular modeling techniques. A factorial design matrix generated eight distinct concentration combinations of NS, MC, and AG, subsequently subjected to <i>in vitro</i> enzyme inhibition assays. Molecular docking analyses using AutoDock Vina, molecular dynamics simulations, MMPBSA calculations, and principal component analysis, were executed with Gromacs to discern the interaction dynamics between the compounds and target enzymes. A formulation comprising NS:MC:AG at a 215:50:35\u00a0\u03bcg/mL ratio yielded significant inhibition of pancreatic lipase (IC50: 74.26\u00a0\u00b1\u00a04.27\u00a0\u03bcg/mL). Moreover, a concentration combination of 215:80:35\u00a0\u03bcg/mL effectively inhibited both \u03b1-glucosidase (IC<sub>50</sub>: 66.09\u00a0\u00b1\u00a03.98\u00a0\u03bcg/mL) and HMGCR (IC<sub>50</sub>: 129.03\u00a0\u03bcg/mL). Notably, MC-derived compounds exhibited superior binding affinity towards all three enzymes, compared to their reference molecules, with diosgenin, Momordicoside I, and diosgenin displaying binding affinities of -11.0, -8.8, and -7.9\u00a0kcal/mol with active site residues of pancreatic lipase, \u03b1-glucosidase, and HMGCR, respectively. Further, 100 ns molecular dynamics simulations revealed the formation and stabilization of non-bonded interactions between the compounds and the enzymes' active site residues. Through a synergistic application of <i>in vitro</i> and molecular modeling methodologies, this study substantiated the potent inhibitory activity of the NS:MC:AG blend (at a ratio of 215:80:35\u00a0\u03bcg/mL) and specific MC compounds against pancreatic lipase, \u03b1-glucosidase, and HMGCR. These findings provide invaluable insights into the molecular underpinnings of these medicinal plants' anti-diabetic and anti-obesity effects and may guide future therapeutic development."], "CopyrightInformation": "\u00a9 2024 The Authors."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, KLE College of Pharmacy, Belagavi, KLE Academy of Higher Education and Research, Belagavi 590010, Karnataka, India."}], "LastName": "Chavan", "ForeName": "Rajashekar S", "Initials": "RS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, KLE College of Pharmacy, Belagavi, KLE Academy of Higher Education and Research, Belagavi 590010, Karnataka, India."}], "LastName": "Khatib", "ForeName": "Nayeem A", "Initials": "NA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, KLE College of Pharmacy, Bengaluru, Karnataka, India."}], "LastName": "Hariprasad", "ForeName": "M G", "Initials": "MG"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, KLE College of Pharmacy, Belagavi, KLE Academy of Higher Education and Research, Belagavi 590010, Karnataka, India."}], "LastName": "Patil", "ForeName": "Vishal S", "Initials": "VS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, KLE College of Pharmacy, Bengaluru, Karnataka, India."}], "LastName": "Redhwan", "ForeName": "Moqbel Ali Moqbel", "Initials": "MAM"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Heliyon", "NlmUniqueID": "101672560", "ISSNLinking": "2405-8440"}, "CoiStatement": "The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Graf B.L., Raskin I., Cefalu W.T., Ribnicky D.M. Plant-derived therapeutics for the treatment of metabolic syndrome. Curr. Opin. Invest. Drugs. 2010;11(10):1107. (London, England: 2000)", "ArticleIdList": ["PMC3755736", "20872313"]}, {"Citation": "Rochlani Y., Pothineni N.V., Kovelamudi S., Mehta J.L. Metabolic syndrome: pathophysiology, management, and modulation by natural compounds. Ther Adv Cardiovasc Dis. 2017;11(8):215\u2013225.", "ArticleIdList": ["PMC5933580", "28639538"]}, {"Citation": "Matsuzawa Y., Funahashi T., Nakamura T. The concept of metabolic syndrome: contribution of visceral fat accumulation and its molecular mechanism. J. Atherosclerosis Thromb. 2011;18(8):629\u2013639.", "ArticleIdList": ["21737960"]}, {"Citation": "Hiyoshi T., Fujiwara M., Yao Z. Postprandial hyperglycemia and postprandial hypertriglyceridemia in type 2 diabetes. Journal of Biomedical Research. 2017;33(1):1\u201316.", "ArticleIdList": ["PMC6352876", "29089472"]}, {"Citation": "Meza C.A., La Favor J.D., Kim D.H., Hickner R.C. Endothelial dysfunction: is there a hyperglycemia-induced imbalance of NOX and NOS? Int. J. Mol. Sci. 2019;20(15):3775.", "ArticleIdList": ["PMC6696313", "31382355"]}, {"Citation": "Zhu G., Fang Q., Zhu F., Huang D., Yang C. Structure and function of pancreatic lipase-related protein 2 and its relationship with pathological states. Front. Genet. 2021;12", "ArticleIdList": ["PMC8287333", "34290745"]}, {"Citation": "Panwar U., Singh S.K. Identification of novel pancreatic lipase inhibitors using in silico studies. Endocrine, metabolic & immune disorders-drug targets (formerly current drug targets-immune, endocrine & metabolic disorders) 2019;19(4):449\u2013457.", "ArticleIdList": ["30484411"]}, {"Citation": "Khanal P., Dwivedi P.S., Patil V.S., Shetty A., Aga A., Javaid A., Bhandare V.V. Barosmin against postprandial hyperglycemia: outputs from computational prediction to functional responses in vitro. J. Biomol. Struct. Dyn. 2023:1\u20137.", "ArticleIdList": ["37458811"]}, {"Citation": "Khanal P., Patil B.M. Gene set enrichment analysis of alpha-glucosidase inhibitors from Ficus benghalensis. Asian Pac. J. Trop. Biomed. 2019;9(6):263\u2013270."}, {"Citation": "Seshadri S., Rapaka N., Prajapati B., Mandaliya D., Patel S., Muggalla C.S., et al. Statins exacerbate glucose intolerance and hyperglycemia in a high sucrose fed rodent model. Sci. Rep. 2019;9(1):1\u20139. doi: 10.1038/s41598-019-45369-8.", "ArticleIdList": ["10.1038/s41598-019-45369-8", "PMC6584635", "31217552"]}, {"Citation": "Igel M., Sudhop T., von Bergmann K. Pharmacology of 3\u2010hydroxy\u20103\u2010methylglutaryl\u2010coenzyme A reductase inhibitors (statins), including rosuvastatin and pitavastatin. J. Clin. Pharmacol. 2002;42(8):835\u2013845. doi: 10.1177/009127002401102731.", "ArticleIdList": ["10.1177/009127002401102731", "12162466"]}, {"Citation": "Ridker P.M., Pradhan A., MacFadyen J.G., Libby P., Glynn R.J. Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial. Lancet. 2012;380(9841):565\u2013571. doi: 10.1016/S0140-6736(12)61190-8.", "ArticleIdList": ["10.1016/S0140-6736(12)61190-8", "PMC3774022", "22883507"]}, {"Citation": "Sattar N., Preiss D., Murray H.M., Welsh P., Buckley B.M., de Craen A.J., et al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet. 2010;375(9716):735\u2013742.", "ArticleIdList": ["20167359"]}, {"Citation": "Nyakudya T.T., Tshabalala T., Dangarembizi R., Erlwanger K.H., Ndhlala A.R. The potential therapeutic value of medicinal plants in the management of metabolic disorders. Molecules. 2020;25(11):2669.", "ArticleIdList": ["PMC7321241", "32526850"]}, {"Citation": "Ahmed M., Kumari N., Mirgani Z., Saeed A., Ramadan A., Ahmed M.H., Almobarak A.O. Metabolic syndrome; Definition, Pathogenesis, Elements, and the Effects of medicinal plants on it's elements. J. Diabetes Metab. Disord. 2022;21(1):1011\u20131022.", "ArticleIdList": ["PMC9167315", "35673459"]}, {"Citation": "Balekundri A., Shahapuri A., Patil M. Poly-herbal tablet formulation by design expert tool and in vitro anti-lipase activity. Future Journal of Pharmaceutical Sciences. 2020;6(1):1. 1."}, {"Citation": "Jain A., Jain S.K. Formulation and optimization of temozolomide nanoparticles by 3 factor 2 level factorial design. Biomatter. 2013;3(2)", "ArticleIdList": ["PMC3749802", "23719178"]}, {"Citation": "Gaonkar V.P., Mannur V.S., Mastiholimath V.S., Hullatti K.K. Development and evaluation of herbal supplement: a quality by design approach. Indian J. Pharmaceut. Sci. 2020;82(4)"}, {"Citation": "Shete R.B., Muniswamy V.J., Pandit A.P., Khandelwal K.R. Formulation of eco-friendly medicated chewing gum to prevent motion sickness. AAPS PharmSciTech. 2015;16(5):1041\u20131050.", "ArticleIdList": ["PMC4674635", "25652732"]}, {"Citation": "Singleton V.L., Orthofer R., Lamuela-Raventos R.M. Analysis of total phenols and other oxidation substrates and antioxidants by means of Folin-Ciocalteu reagent. Methods Enzymol. 1999;299:152\u2013179."}, {"Citation": "Delcour J., Varebeke D.J. Anew colorimetricassay for flavonoidsinpilsnerbeers. J. Institute. Brewing 91. 1985:37\u201340."}, {"Citation": "Makkar H.P.S. Effect sand fate of tanninsinruminantanimals,adaptation to tanninsandstrategiestoover comedetrimental effect soffeedingtannin-rich feeds. Small Rumin. Res. 2003;49:241\u2013256."}, {"Citation": "Blois M.S. Antioxidant determinations by the use of a stable free radical. Nature. 1958;181:1199\u20131200. doi: 10.1038/1811199a0.", "ArticleIdList": ["10.1038/1811199a0"]}, {"Citation": "Bustanji Y., Issa A., Mohammad M., Hudaib M., Tawah K., Alkhatib H., Almasri I., Al-Khalidi B. Inhibition of hormone-sensitive lipase and pancreatic lipase by Rosmarinus officinalis extract and selected phenolic constituents. J. Med. Plants Res. 2010;4:2235\u20132242."}, {"Citation": "Zheng C.-D., Duan Y.-Q., Gao J.-M., Ruan Z.-G. Screening for anti-lipase properties of 37 traditional Chinese medicinal herbs. J. Chin. Med. Assoc. 2010;73:319\u2013324.", "ArticleIdList": ["20603090"]}, {"Citation": "Khanal P., Patil B. Gene set enrichment analysis of alpha-glucosidase inhibitors from Ficus benghalensis. Asian Pac. J. Trop. Biomed. 2019;9(6):263\u2013270."}, {"Citation": "Salvamani S., Gunasekaran B., Shukor M.Y., Shaharuddin N.A., Sabullah M.K., Ahmad S.A. Anti-HMG-CoA reductase, antioxidant, and anti-inflammatory activities of Amaranthus viridis leaf extract as a potential treatment for hypercholesterolemia. Evid. base Compl. Alternative Med. 2016:10.", "ArticleIdList": ["PMC4804040", "27051453"]}, {"Citation": "Egloff M.P., Marguet F., Buono G., Verger R., Cambillau C., van Tilbeurgh H. The 2.46. ANG. resolution structure of the pancreatic lipase-colipase complex inhibited by a C11 alkyl phosphonate. Biochemistry. 1995 Mar 1;34(9):2751\u20132762.", "ArticleIdList": ["7893686"]}, {"Citation": "Roig-Zamboni V., Cobucci-Ponzano B., Iacono R., Ferrara M.C., Germany S., Bourne Y., Parenti G., Moracci M., Sulzenbacher G. Structure of human lysosomal acid \u03b1-glucosidase\u2013a guide for the treatment of Pompe disease. Nat. Commun. 2017 Oct 24;8(1):1111.", "ArticleIdList": ["PMC5653652", "29061980"]}, {"Citation": "Istvan E.S., Deisenhofer J. Structural mechanism for statin inhibition of HMG-CoA reductase. Science. 2001 May 11;292(5519):1160\u20131164.", "ArticleIdList": ["11349148"]}, {"Citation": "Samdani A., Vetrivel U. POAP: a GNU parallel based multithreaded pipeline of open babel and AutoDock suite for boosted high throughput virtual screening. Comput. Biol. Chem. 2018 Jun 1;74:39\u201348.", "ArticleIdList": ["29533817"]}, {"Citation": "Van Der Spoel D., Lindahl E., Hess B., Groenhof G., Mark A.E., Berendsen H.J. GROMACS: fast, flexible, and free. J. Comput. Chem. 2005;26(16):1701\u20131718.", "ArticleIdList": ["16211538"]}, {"Citation": "Kumari R., Kumar R., Lynn A. g_mmpbsa\u2013a GROMACS tool for high-throughput MM-PBSA calculations. J. Chem. Inf. Model. 2014;54(7):1951\u20131962.", "ArticleIdList": ["24850022"]}, {"Citation": "Bhattacharya K., Khanal P., Patil V.S., Dwivedi P.S., Chanu N.R., Chaudhary R.K., Deka S., Chakraborty A. Computational pharmacology profiling of borapetoside C against melanoma. J. Biomol. Struct. Dyn. 2023 May 11:1\u20136.", "ArticleIdList": ["37203884"]}, {"Citation": "Hess B. Similarities between principal components of protein dynamics and random diffusion. Physical Review. E, Statistical Physics, Plasmas, Fluids, and Related Interdisciplinary Topics. 2000;62(6 Pt B):8438\u20138448.", "ArticleIdList": ["11138145"]}, {"Citation": "Shivanagoudra S.R., Perera W.H., Perez J.L., Athrey G., Sun Y., Wu C.S., Jayaprakasha G.K., Patil B.S. In vitro and in silico elucidation of antidiabetic and anti-inflammatory activities of bioactive compounds from Momordica charantia L. Bioorg. Med. Chem. 2019 Jul 15;27(14):3097\u20133109.", "ArticleIdList": ["31196754"]}, {"Citation": "Yue J., Xu J., Cao J., Zhang X., Zhao Y. Cucurbitane triterpenoids from Momordica charantia L. and their inhibitory activity against \u03b1 -glucosidase, \u03b1 -amylase and protein tyrosine phosphatase 1B (PTP1B) J. Funct.Foods. 2017;37:624\u2013631."}, {"Citation": "Lunagariya N.A., Patel N.K., Jagtap S.C., Bhutani K.K. Inhibitors of pancreatic lipase: state of the art and clinical perspectives. EXCLI J. 2014 Aug 22;13:897\u2013921.", "ArticleIdList": ["PMC4464291", "26417311"]}, {"Citation": "Jesus M., Martins A.P., Gallardo E., Silvestre S. Diosgenin: recent highlights on pharmacology and analytical methodology. Journal of analytical methods in chemistry. 2016 2016 Oct.", "ArticleIdList": ["PMC5225340", "28116217"]}, {"Citation": "Uemura T., Hirai S., Mizoguchi N., et al. Diosgenin present in fenugreek improves glucose metabolism by promoting adipocyte differentiation and inhibiting inflammation in adipose tissues. Mol. Nutr. Food Res. 2010;54(11):1596\u20131608.", "ArticleIdList": ["20540147"]}, {"Citation": "Uemura T., Goto T., Kang M.-S., et al. Diosgenin, the main aglycon of fenugreek, inhibits LXR\u03b1 activity in HepG2 cells and decreases plasma and hepatic triglycerides in obese diabetic mice. J. Nutr. 2011;141(1):17\u201323.", "ArticleIdList": ["21106928"]}, {"Citation": "Sangeetha M.K., Shrishri Mal N., Atmaja K., Sali V.K., Vasanthi H.R. PPAR's and Diosgenin a chemico biological insight in NIDDM. Chem. Biol. Interact. 2013;206(2):403\u2013410.", "ArticleIdList": ["24001619"]}, {"Citation": "Lv Y.-C., Yang J., Yao F., et al. Diosgenin inhibits atherosclerosis via suppressing the MiR-19b-induced downregulation of ATP-binding cassette transporter A1. Atherosclerosis. 2015;240(1):80\u201389.", "ArticleIdList": ["25765596"]}, {"Citation": "Shivanagoudra S.R., Perera W.H., Perez J.L., Athrey G., Sun Y., Wu C.S., Jayaprakasha G.K., Patil B.S. In vitro and in silico elucidation of antidiabetic and anti-inflammatory activities of bioactive compounds from Momordica charantia L. Bioorg. Med. Chem. 2019 Jul 15;27(14):3097\u20133109.", "ArticleIdList": ["31196754"]}, {"Citation": "Yue J., Xu J., Cao J., Zhang X., Zhao Y. Cucurbitane triterpenoids from Momordica charantia L. and their inhibitory activity against \u03b1 -glucosidase, \u03b1 -amylase and protein tyrosine phosphatase 1B (PTP1B) J. Funct.Foods. 2017;37:624\u2013631."}, {"Citation": "Lunagariya N.A., Patel N.K., Jagtap S.C., Bhutani K.K. Inhibitors of pancreatic lipase: state of the art and clinical perspectives. EXCLI J. 2014 Aug 22;13:897\u2013921.", "ArticleIdList": ["PMC4464291", "26417311"]}, {"Citation": "Jesus M., Martins A.P., Gallardo E., Silvestre S. Diosgenin: recent highlights on pharmacology and analytical methodology. Journal of analytical methods in chemistry. 2016 2016 Oct.", "ArticleIdList": ["PMC5225340", "28116217"]}, {"Citation": "Uemura T., Hirai S., Mizoguchi N., et al. Diosgenin present in fenugreek improves glucose metabolism by promoting adipocyte differentiation and inhibiting inflammation in adipose tissues. Mol. Nutr. Food Res. 2010;54(11):1596\u20131608.", "ArticleIdList": ["20540147"]}, {"Citation": "Uemura T., Goto T., Kang M.-S., et al. Diosgenin, the main aglycon of fenugreek, inhibits LXR\u03b1 activity in HepG2 cells and decreases plasma and hepatic triglycerides in obese diabetic mice. J. Nutr. 2011;141(1):17\u201323.", "ArticleIdList": ["21106928"]}, {"Citation": "Sangeetha M.K., Shrishri Mal N., Atmaja K., Sali V.K., Vasanthi H.R. PPAR's and Diosgenin a chemico biological insight in NIDDM. Chem. Biol. Interact. 2013;206(2):403\u2013410.", "ArticleIdList": ["24001619"]}, {"Citation": "Lv Y.-C., Yang J., Yao F., et al. Diosgenin inhibits atherosclerosis via suppressing the MiR-19b-induced downregulation of ATP-binding cassette transporter A1. Atherosclerosis. 2015;240(1):80\u201389.", "ArticleIdList": ["25765596"]}]}], "History": [{"Year": "2023", "Month": "10", "Day": "14"}, {"Year": "2024", "Month": "1", "Day": "16"}, {"Year": "2024", "Month": "1", "Day": "17"}, {"Year": "2024", "Month": "2", "Day": "2", "Hour": "6", "Minute": "43"}, {"Year": "2024", "Month": "2", "Day": "2", "Hour": "6", "Minute": "42"}, {"Year": "2024", "Month": "2", "Day": "2", "Hour": "4", "Minute": "13"}, {"Year": "2024", "Month": "1", "Day": "18"}], "PublicationStatus": "epublish", "ArticleIdList": ["38304787", "PMC10830859", "10.1016/j.heliyon.2024.e24907", "S2405-8440(24)00938-1"]}}]}